Neoplasms Metastasis Unknown Status Phase 3 Trials for Erlotinib (DB00530)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Unknown Status3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00268684Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC